202 related articles for article (PubMed ID: 19057265)
1. Reclassification of neuroendocrine tumors improves the separation of carcinoids and the prediction of survival.
Skov BG; Krasnik M; Lantuejoul S; Skov T; Brambilla E
J Thorac Oncol; 2008 Dec; 3(12):1410-5. PubMed ID: 19057265
[TBL] [Abstract][Full Text] [Related]
2. Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement.
Thomas CF; Tazelaar HD; Jett JR
Chest; 2001 Apr; 119(4):1143-50. PubMed ID: 11296182
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
Correia Sda S; Pinto C; Bernardo J
Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
[TBL] [Abstract][Full Text] [Related]
5. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of tumor size eliminating the ground glass opacity component: modified clinical T descriptors of the tumor, node, metastasis classification of lung cancer.
Nakamura S; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ishiguro F; Hirakawa A; Yokoi K
J Thorac Oncol; 2013 Dec; 8(12):1551-7. PubMed ID: 24389437
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
Langfort R; Rudziński P; Burakowska B
Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
[TBL] [Abstract][Full Text] [Related]
8. Validity of International Association for the Study Of Lung Cancer proposals for the revision of N descriptors in lung cancer.
Lee JG; Lee CY; Bae MK; Park IK; Kim DJ; Kim KD; Chung KY
J Thorac Oncol; 2008 Dec; 3(12):1421-6. PubMed ID: 19057267
[TBL] [Abstract][Full Text] [Related]
9. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
10. Bronchial carcinoid tumors: nodal status and long-term survival after resection.
Cardillo G; Sera F; Di Martino M; Graziano P; Giunti R; Carbone L; Facciolo F; Martelli M
Ann Thorac Surg; 2004 May; 77(5):1781-5. PubMed ID: 15111186
[TBL] [Abstract][Full Text] [Related]
11. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
[TBL] [Abstract][Full Text] [Related]
12. Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?
Wei S; Asamura H; Kawachi R; Sakurai H; Watanabe S
J Thorac Oncol; 2011 Feb; 6(2):310-8. PubMed ID: 21206387
[TBL] [Abstract][Full Text] [Related]
13. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis.
Kao HL; Chang WC; Li WY; Chia-Heng Li A; Fen-Yau Li A
Am J Surg Pathol; 2012 Feb; 36(2):185-92. PubMed ID: 22082601
[TBL] [Abstract][Full Text] [Related]
14. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM
Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
[TBL] [Abstract][Full Text] [Related]
16. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.
Skov BG; Holm B; Erreboe A; Skov T; Mellemgaard A
J Thorac Oncol; 2010 Apr; 5(4):453-9. PubMed ID: 20104194
[TBL] [Abstract][Full Text] [Related]
17. Radical mediastinal nodal removal improves disease-free survival for pulmonary low-grade malignant tumors.
Zheng H; Xie HK; Li C; Bao F; Ding JA; Jiang GN; Zhang RX; Chen C
Lung Cancer; 2012 Mar; 75(3):342-7. PubMed ID: 21840617
[TBL] [Abstract][Full Text] [Related]
18. Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database.
Yoshida J; Nagai K; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
J Thorac Oncol; 2009 Aug; 4(8):959-63. PubMed ID: 19458555
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
20. Lung carcinoids. Tumor angiogenesis in relation to clinicopathologic characteristics.
Slodkowska J; Sikora J; Androsiuk W; Rudziński P; Radomyski A
Anal Quant Cytol Histol; 1999 Jun; 21(3):267-72. PubMed ID: 10560502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
